Involvement of upregulation of DEPDC1 (DEP domain containing 1) in bladder carcinogenesis
Open Access
- 23 April 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 26 (44), 6448-6455
- https://doi.org/10.1038/sj.onc.1210466
Abstract
In an attempt to disclose mechanisms of bladder carcinogenesis and discover novel target molecules for development of treatment, we applied a cDNA microarray to screen genes that were significantly transactivated in bladder cancer cells. Among the upregulated genes, we here focused on a novel gene, (DEPDC1) DEP domain containing 1, whose overexpression was confirmed by northern blot and immunohistochemical analyses. Immunocytochemical staining analysis detected strong staining of endogenous DEPDC1 protein in the nucleus of bladder cancer cells. Since DEPDC1 expression was hardly detectable in any of 24 normal human tissues we examined except the testis, we considered this gene-product to be a novel cancer/testis antigen. Suppression of DEPDC1 expression with small-interfering RNA significantly inhibited growth of bladder cancer cells. Taken together, these findings suggest that DEPDC1 might play an essential role in the growth of bladder cancer cells, and would be a promising molecular-target for novel therapeutic drugs or cancer peptide-vaccine to bladder cancers.Keywords
This publication has 23 references indexed in Scilit:
- Elevated expression of protein regulator of cytokinesis 1, involved in the growth of breast cancer cellsCancer Science, 2006
- PDZ-Binding Kinase/T-LAK Cell-Originated Protein Kinase, a Putative Cancer/Testis Antigen with an Oncogenic Activity in Breast CancerCancer Research, 2006
- Expression of Novel Molecules, MICAL2-PV (MICAL2 Prostate Cancer Variants), Increases with High Gleason Score and Prostate Cancer ProgressionClinical Cancer Research, 2006
- UPDATE ON CHEMOTHERAPY FOR ADVANCED BLADDER CANCERJournal of Urology, 2005
- Hypoxia-Inducible Protein 2 (HIG2), a Novel Diagnostic Marker for Renal Cell Carcinoma and Potential Target for Molecular TherapyCancer Research, 2005
- PCOTH, a Novel Gene Overexpressed in Prostate Cancers, Promotes Prostate Cancer Cell Growth through Phosphorylation of Oncoprotein TAF-Iβ/SETCancer Research, 2005
- Multicentre EORTC study 16997: Feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancersEuropean Journal of Cancer, 2005
- Identification of PDZK4, a novel human gene with PDZ domains, that is upregulated in synovial sarcomasOncogene, 2004
- Genome-Wide Profiling of Gene Expression in 29 Normal Human Tissues with a cDNA MicroarrayDNA Research, 2002
- Pleckstrin's repeat performance: a novel domain in G-protein signaling?Trends in Biochemical Sciences, 1996